{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:53:34Z","timestamp":1753887214488,"version":"3.41.2"},"reference-count":21,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This research was partially supported by the Beijing Institute of Technology Innovation and Entrepreneurship Training Program","award":["BIT2023XX336"],"award-info":[{"award-number":["BIT2023XX336"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Drug therapy remains the primary approach to treating tumours. Variability among cancer patients, including variations in genomic profiles, often results in divergent therapeutic responses to analogous anti-cancer drug treatments within the same cohort of cancer patients. Hence, predicting the drug response by analysing the genomic profile characteristics of individual patients holds significant research importance. With the notable progress in machine learning and deep learning, many effective methods have emerged for predicting drug responses utilizing features from both drugs and cell lines. However, these methods are inadequate in capturing a sufficient number of features inherent to drugs. Consequently, we propose a representational approach for drugs that incorporates three distinct types of features: the molecular graph, the SMILE strings, and the molecular fingerprints. In this study, a novel deep learning model, named MCMVDRP, is introduced for the prediction of cancer drug responses. In our proposed model, an amalgamation of these extracted features is performed, followed by the utilization of fully connected layers to predict the drug response based on the IC50 values. Experimental results demonstrate that the presented model outperforms current state-of-the-art models in performance.<\/jats:p>","DOI":"10.1515\/jib-2024-0026","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T09:42:32Z","timestamp":1725270152000},"source":"Crossref","is-referenced-by-count":1,"title":["MCMVDRP: a multi-channel multi-view deep learning framework for cancer drug response prediction"],"prefix":"10.1515","volume":"21","author":[{"given":"Xiangyu","family":"Li","sequence":"first","affiliation":[{"name":"School of Information and Electronics , 47833 Beijing Institute of Technology , Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-5940","authenticated-orcid":false,"given":"Xiumin","family":"Shi","sequence":"additional","affiliation":[{"name":"School of Information and Electronics , 47833 Beijing Institute of Technology , Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxuan","family":"Li","sequence":"additional","affiliation":[{"name":"School of Information and Electronics , 47833 Beijing Institute of Technology , Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-7894","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine , Renmin Hospital of Wuhan University , Wuhan , Hubei , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"2024112723505283571_j_jib-2024-0026_ref_001","doi-asserted-by":"crossref","unstructured":"Marquart, J, Chen, EY, Prasad, V. Estimation of the percentage of US patients with cancer who benefit from genome-driven oncology. JAMA Oncol 2018;4:1093\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2018.1660.","DOI":"10.1001\/jamaoncol.2018.1660"},{"key":"2024112723505283571_j_jib-2024-0026_ref_002","doi-asserted-by":"crossref","unstructured":"Weinstein, JN, Collisson, EA, Mills, GB, Shaw, KRM, Ozenberger, BA, Ellrott, K, et al.. The cancer genome atlas pan-cancer analysis project. Nat Genet 2013;45:1113\u201320. https:\/\/doi.org\/10.1038\/ng.2764.","DOI":"10.1038\/ng.2764"},{"key":"2024112723505283571_j_jib-2024-0026_ref_003","doi-asserted-by":"crossref","unstructured":"Yang, W, Soares, J, Greninger, P, Edelman, EJ, Lightfoot, H, Forbes, S, et al.. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013;41:D955\u201361. https:\/\/doi.org\/10.1093\/nar\/gks1111.","DOI":"10.1093\/nar\/gks1111"},{"key":"2024112723505283571_j_jib-2024-0026_ref_004","doi-asserted-by":"crossref","unstructured":"Barretina, J, Caponigro, G, Stransky, N, Venkatesan, K, Margolin, AA, Kim, S, et al.. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012;483:603\u20137. https:\/\/doi.org\/10.1038\/nature11003.","DOI":"10.1038\/nature11003"},{"key":"2024112723505283571_j_jib-2024-0026_ref_005","doi-asserted-by":"crossref","unstructured":"Shoemaker, RH. The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 2006;6:813\u201323. https:\/\/doi.org\/10.1038\/nrc1951.","DOI":"10.1038\/nrc1951"},{"key":"2024112723505283571_j_jib-2024-0026_ref_006","doi-asserted-by":"crossref","unstructured":"Garnett, MJ, Edelman, EJ, Heidorn, SJ, Greenman, CD, Dastur, A, Lau, KW, et al.. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012;483:570\u20135. https:\/\/doi.org\/10.1038\/nature11005.","DOI":"10.1038\/nature11005"},{"key":"2024112723505283571_j_jib-2024-0026_ref_007","doi-asserted-by":"crossref","unstructured":"Azuaje, F. Computational models for predicting drug responses in cancer research. Briefings Bioinf 2017;18:820\u20139. https:\/\/doi.org\/10.1093\/bib\/bbw065.","DOI":"10.1093\/bib\/bbw065"},{"key":"2024112723505283571_j_jib-2024-0026_ref_008","doi-asserted-by":"crossref","unstructured":"Weininger, D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J Chem Inf Comput Sci 1988;28:31\u20133. https:\/\/doi.org\/10.1021\/ci00057a005.","DOI":"10.1021\/ci00057a005"},{"key":"2024112723505283571_j_jib-2024-0026_ref_009","doi-asserted-by":"crossref","unstructured":"Liu, P, Li, H, Li, S, Leung, KS. Improving prediction of phenotypic drug response on cancer cell lines using deep convolutional network. BMC Bioinf 2019;20:408. https:\/\/doi.org\/10.1186\/s12859-019-2910-6.","DOI":"10.1186\/s12859-019-2910-6"},{"key":"2024112723505283571_j_jib-2024-0026_ref_010","doi-asserted-by":"crossref","unstructured":"Nguyen, T, Nguyen, GTT, Nguyen, T, Le, DH. Graph convolutional networks for drug response prediction. IEEE ACM Trans Comput Biol Bioinf 2022;19:146\u201354. https:\/\/doi.org\/10.1109\/tcbb.2021.3060430.","DOI":"10.1109\/TCBB.2021.3060430"},{"key":"2024112723505283571_j_jib-2024-0026_ref_011","unstructured":"Guo, Y, Shi, X, Zhou, H. A deep learning drug-target binding affinity prediction based on compound microstructure and its application in COVID-19 drug screening. J Beijing Inst Technol 2023;32:396\u2013405."},{"key":"2024112723505283571_j_jib-2024-0026_ref_012","doi-asserted-by":"crossref","unstructured":"Zhou, H, Shi, X, Wang, Y, Wen, Z, Peng, J. XG-DTA: drug-target affinity prediction based on drug molecular graph and protein sequence combined with XLNet. In: 2023 IEEE international conference on medical artificial intelligence (MedAI); 2023:189\u201396 pp.","DOI":"10.1109\/MedAI59581.2023.00031"},{"key":"2024112723505283571_j_jib-2024-0026_ref_013","doi-asserted-by":"crossref","unstructured":"Chu, T, Nguyen, TT, Hai, BD, Nguyen, QH, Nguyen, T. Graph transformer for drug response prediction. IEEE ACM Trans Comput Biol Bioinf 2023;20:1065\u201372. https:\/\/doi.org\/10.1109\/tcbb.2022.3206888.","DOI":"10.1109\/TCBB.2022.3206888"},{"key":"2024112723505283571_j_jib-2024-0026_ref_014","doi-asserted-by":"crossref","unstructured":"Yan, X, Liu, Y, Zhang, W. Deep graph and sequence representation learning for drug response prediction. In: Artificial neural networks and machine learning \u2013 ICANN 2022: 31st international conference on artificial neural networks, Bristol, UK, September 6\u20139, 2022, proceedings, part I. Berlin, Heidelberg: Springer-Verlag; 2022:97\u2013108 pp.","DOI":"10.1007\/978-3-031-15919-0_9"},{"key":"2024112723505283571_j_jib-2024-0026_ref_015","doi-asserted-by":"crossref","unstructured":"Huang, C, Mezencev, R, McDonald, JF, Vannberg, F. Open source machine-learning algorithms for the prediction of optimal cancer drug therapies. PLoS One 2017;12:e0186906. https:\/\/doi.org\/10.1371\/journal.pone.0186906.","DOI":"10.1371\/journal.pone.0186906"},{"key":"2024112723505283571_j_jib-2024-0026_ref_016","doi-asserted-by":"crossref","unstructured":"Tan, M, \u00d6zg\u00fcl, OF, Bardak, B, Ek\u015fio\u011flu, I, Sabuncuo\u011flu, S. Drug response prediction by ensemble learning and drug-induced gene expression signatures. Genomics 2019;111:1078\u201388. https:\/\/doi.org\/10.1016\/j.ygeno.2018.07.002.","DOI":"10.1016\/j.ygeno.2018.07.002"},{"key":"2024112723505283571_j_jib-2024-0026_ref_017","doi-asserted-by":"crossref","unstructured":"Zhang, N, Wang, H, Fang, Y, Wang, J, Zheng, X, Liu, XS. Predicting anticancer drug responses using a dual-layer integrated cell line-drug network model. PLoS Comput Biol 2015;11:e1004498. https:\/\/doi.org\/10.1371\/journal.pcbi.1004498.","DOI":"10.1371\/journal.pcbi.1004498"},{"key":"2024112723505283571_j_jib-2024-0026_ref_018","doi-asserted-by":"crossref","unstructured":"Zhang, H, Lu, G, Zhan, M, Zhang, B. Semi-supervised classification of graph convolutional networks with laplacian rank constraints. Neural Process Lett 2022;54:2645\u201356. https:\/\/doi.org\/10.1007\/s11063-020-10404-7.","DOI":"10.1007\/s11063-020-10404-7"},{"key":"2024112723505283571_j_jib-2024-0026_ref_019","unstructured":"Veli\u010dkovi\u0107, P, Cucurull, G, Casanova, A, Romero, A, Li\u00f2, P, Bengio, Y. Graph attention networks. In: Proceedings of the international conference on learning representations. Vancouver, BC, Canada, 30 April\u20133 May; 2018."},{"key":"2024112723505283571_j_jib-2024-0026_ref_020","doi-asserted-by":"crossref","unstructured":"Yang, J, Cai, Y, Zhao, K, Xie, H, Chen, X. Concepts and applications of chemical fingerprint for hit and lead screening. Drug Discov Today 2022;27:103356. https:\/\/doi.org\/10.1016\/j.drudis.2022.103356.","DOI":"10.1016\/j.drudis.2022.103356"},{"key":"2024112723505283571_j_jib-2024-0026_ref_021","unstructured":"Ramsundar, B, Eastman, P, Walters, P, Pande, V. Deep learning for the life sciences: applying deep learning to genomics, microscopy, drug discovery, and more. Sebastopol, CA: O\u2019Reilly Media; 2019."}],"container-title":["Journal of Integrative Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2024-0026\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2024-0026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T23:51:24Z","timestamp":1732751484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jib-2024-0026\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,11,27]]}},"alternative-id":["10.1515\/jib-2024-0026"],"URL":"https:\/\/doi.org\/10.1515\/jib-2024-0026","relation":{},"ISSN":["1613-4516"],"issn-type":[{"type":"electronic","value":"1613-4516"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"article-number":"20240026"}}